The FLUOROLESS HBP Trial

The objective of this study is to assess the feasibility, accuracy and safety of performing Fluoroless (or low Fluoro) conduction system pacing utilizing electro-anatomic mapping (EAM) with the CARTO 3 mapping system in comparison to a group of patients undergoing conventional conduction system pacing (CSP) implants.

In order to participate you must meet the following criteria:

• Are > 18 years of age.
• Have current indication for Permanent Pacemaker implantation or implantation of a Cardiac Resynchronization Therapy device based on current guidelines.

You will be excluded from the study if any of the following criteria apply to you:

• Have existing device (pacemaker or CRT).
• Are not to provide consent for themselves either due to medical or psychiatric comorbidity.
• Are pregnant.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.